脊髓型颈椎病前路手术治疗的初步临床报告

目的观察在甲基强的松龙保护下颈椎前路手术治疗脊髓型颈椎病的临床疗效。方法28例脊髓型颈椎病患者实施颈椎前路间隙减压自体髂骨植骨、开槽减压钛网植入与cage植入钢板内固定术，28例患者全部获得随访，随访时间平均12个月。结果采用JOA评分评定临床效果，JOA评分13～16分，平均13．2分，其中优24例，良4例。椎间植膏、在3～5个月内融合，无骨不连及假关节形成。结论甲基强的松龙在术中与术后能够很好地保护脊髓功能；颈椎前路减压融合内固定术治疗脊髓型颈椎病临床疗效满意，是较好的手术方式。

The preliminary reports of anterior route operation therapy for cervical spondylotic myelopathy

Objective To evaluate the clinical effect of cervical spondylotic myelopathy（CSM） for undergoing operation therapy under the conservation of methylprednisonlone （MP）. Methods 28 eases of CSM who underwent iliac autograft fusion and cage and titanium rete implantation after anterior cervical interbody decompression that were carried out titanium plate internal fixation. All cases were followed up （average 12 months）. Results The Japanese Orthopaedic Association（JOA） was adopted to assess the clinical effect, JOA＇ score was for 13-16 points （average 13.2 Points） ,Among which,24 cases were excellent and 4 cases fine. Intervertebral autograft could fuse among 3- 5 months and had no nonunion and pseudoarthrosis formation. Conclusions Methylprednisolone（MP） could protect the spinal cord function well in anterior route operation. It was satisfactory and a well kinds of operative method that cervical anterior route decompression and fusion and internal fixation cured cervical spondylotic myelopathy.